Insider Buy/Sell Details for the Healthcare Sector — May 2026
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1917)
ASTRAZENECA PLC (AZN)
Sharma Mani — SVP, Group Controller and Head of Global Finance Services
Shares
11,893
Price
$185.78
Total Value
$2.21M
Shares Held After
19,262
% of Holdings
38.2%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,563
Price
$64.43
Total Value
$100.71K
Shares Held After
490,000
% of Holdings
0.3%
Pharvaris N.V. (PHVS)
Bjork Elisabeth — Director
Shares
10,000
Price
$29.32
Total Value
$293.17K
Shares Held After
15,167
% of Holdings
39.7%
AtriCure, Inc. (ATRC)
Prange Karen — Director
Shares
3,000
Price
$28.65
Total Value
$85.95K
Shares Held After
26,373
% of Holdings
10.2%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
13,684
Price
$52.75
Total Value
$721.84K
Shares Held After
18,197
% of Holdings
42.9%
Annovis Bio, Inc. (ANVS)
Hoffman Michael B — Director
Shares
54,933
Price
$1.90
Total Value
$104.37K
Shares Held After
3,364,883
% of Holdings
1.6%
Annovis Bio, Inc. (ANVS)
Hoffman Michael B — Director
Shares
18,849
Price
$1.80
Total Value
$33.93K
Shares Held After
3,309,950
% of Holdings
0.6%
Annovis Bio, Inc. (ANVS)
Hoffman Michael B — Director
Shares
2,562
Price
$1.75
Total Value
$4.48K
Shares Held After
3,291,101
% of Holdings
0.1%
BIOLIFE SOLUTIONS INC (BLFS)
Casdin Partners Master Fund, L.P. — 10% Owner
Shares
250,000
Price
$23.70
Total Value
$5.92M
Shares Held After
5,407,165
% of Holdings
4.4%
Aveanna Healthcare Holdings, Inc. (AVAH)
Cunningham Patrick A. — Chief Compliance Officer
Shares
125,000
Price
$7.59
Total Value
$948.54K
Shares Held After
212,755
% of Holdings
37.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,500
Price
$0.92
Total Value
$1.38K
Shares Held After
293,266
% of Holdings
0.5%
CVS HEALTH Corp (CVS)
ROBBINS LARRY — Director
Shares
800
Price
$96.28
Total Value
$77.03K
Shares Held After
5,195,261
% of Holdings
0.0%
CVS HEALTH Corp (CVS)
ROBBINS LARRY — Director
Shares
66,881
Price
$95.67
Total Value
$6.40M
Shares Held After
5,196,061
% of Holdings
1.3%
CVS HEALTH Corp (CVS)
ROBBINS LARRY — Director
Shares
152,691
Price
$94.81
Total Value
$14.48M
Shares Held After
5,262,942
% of Holdings
2.8%
CVS HEALTH Corp (CVS)
ROBBINS LARRY — Director
Shares
797,628
Price
$93.48
Total Value
$74.56M
Shares Held After
5,415,633
% of Holdings
12.8%
Seer, Inc. (SEER)
Horn David R. — PRESIDENT & CFO
Shares
7,303
Price
$1.69
Total Value
$12.35K
Shares Held After
493,959
% of Holdings
1.5%
BOSTON SCIENTIFIC CORP (BSX)
Habiger David C — Director
Shares
2,250
Price
$55.92
Total Value
$125.82K
Shares Held After
13,878
% of Holdings
16.2%
BOSTON SCIENTIFIC CORP (BSX)
LUDWIG EDWARD J — Director
Shares
3,580
Price
$56.68
Total Value
$202.91K
Shares Held After
25,359
% of Holdings
14.1%
BOSTON SCIENTIFIC CORP (BSX)
Pegus Cheryl — Director
Shares
1,770
Price
$56.49
Total Value
$99.99K
Shares Held After
1,770
% of Holdings
100.0%
Lucid Diagnostics Inc. (LUCD)
Matheis Dennis — Director
Shares
245,000
Price
$1.00
Total Value
$245.27K
Shares Held After
1,033,443
% of Holdings
23.7%
Hinge Health, Inc. (HNGE)
Budge James — Chief Financial Officer
Shares
781
Price
$55.34
Total Value
$43.22K
Shares Held After
451,293
% of Holdings
0.2%
Progyny, Inc. (PGNY)
Livingston Mark S. — CHIEF FINANCIAL OFFICER
Shares
8,275
Price
$25.50
Total Value
$211.01K
Shares Held After
79,063
% of Holdings
9.5%
Entrada Therapeutics, Inc. (TRDA)
Zeiher Bernhardt G — Director
Shares
5,000
Price
$5.86
Total Value
$29.32K
Shares Held After
5,000
% of Holdings
100.0%
ClearPoint Neuro, Inc. (CLPT)
FALLON LYNNETTE C — Director
Shares
5,091
Price
$11.14
Total Value
$56.71K
Shares Held After
48,227
% of Holdings
9.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$577.26
Total Value
$115.45K
Shares Held After
40,513
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
245
Price
$574.08
Total Value
$140.65K
Shares Held After
40,713
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
195
Price
$573.00
Total Value
$111.73K
Shares Held After
40,958
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
376
Price
$571.41
Total Value
$214.85K
Shares Held After
41,153
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
552
Price
$570.38
Total Value
$314.85K
Shares Held After
41,529
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
660
Price
$569.30
Total Value
$375.74K
Shares Held After
42,081
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
412
Price
$568.34
Total Value
$234.15K
Shares Held After
42,741
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$566.89
Total Value
$158.73K
Shares Held After
43,153
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
840
Price
$565.95
Total Value
$475.39K
Shares Held After
43,433
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,280
Price
$564.81
Total Value
$722.95K
Shares Held After
44,273
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,949
Price
$563.97
Total Value
$1.10M
Shares Held After
45,553
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,071
Price
$562.94
Total Value
$1.17M
Shares Held After
47,502
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$562.01
Total Value
$247.28K
Shares Held After
49,573
% of Holdings
0.9%
Precipio, Inc. (PRPO)
SANDBERG RICHARD A — Director
Shares
2,034
Price
$24.89
Total Value
$50.63K
Shares Held After
8,142
% of Holdings
20.0%
Precipio, Inc. (PRPO)
SANDBERG RICHARD A — Director
Shares
500
Price
$25.00
Total Value
$12.50K
Shares Held After
3,900
% of Holdings
11.4%
FATE THERAPEUTICS INC (FATE)
TAHL CINDY — Chief Legal and Compliance Officer
Shares
25,590
Price
$1.88
Total Value
$48.08K
Shares Held After
628,155
% of Holdings
3.9%
FATE THERAPEUTICS INC (FATE)
Valamehr Bahram — Director
Shares
28,946
Price
$1.88
Total Value
$54.48K
Shares Held After
635,762
% of Holdings
4.4%
Immunovant, Inc. (IMVT)
Pande Atul — Director
Shares
6,000
Price
$32.00
Total Value
$192.00K
Shares Held After
116,731
% of Holdings
4.9%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$61.30
Total Value
$1.53M
Shares Held After
1,123,095
% of Holdings
2.2%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
85,895
Price
$0.43
Total Value
$36.93K
Shares Held After
955,447
% of Holdings
8.2%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP & Chief Mfg and Supply Cha
Shares
18
Price
$440.38
Total Value
$7.93K
Shares Held After
1,559
% of Holdings
1.1%
MARIMED INC. (MRMD)
Levine Jon R — Director
Shares
40,000
Price
$0.07
Total Value
$3.00K
Shares Held After
21,247,986
% of Holdings
0.2%
HEALTHSTREAM INC (HSTM)
O'Hara Kevin P — Executive Vice President
Shares
3,000
Price
$24.08
Total Value
$72.23K
Shares Held After
20,982
% of Holdings
12.5%
AVITA Medical, Inc. (RCEL)
O'Toole David D — CFO
Shares
2,000
Price
$4.26
Total Value
$8.52K
Shares Held After
145,927
% of Holdings
1.4%
Serina Therapeutics, Inc. (SER)
Marshall Richard Peter — Director
Shares
12,183
Price
$1.65
Total Value
$20.10K
Shares Held After
12,183
% of Holdings
100.0%
BIOLIFE SOLUTIONS INC (BLFS)
Casdin Partners Master Fund, L.P. — 10% Owner
Shares
300,000
Price
$22.65
Total Value
$6.79M
Shares Held After
5,657,165
% of Holdings
5.0%
Showing 601–650 of 1917 transactions (page 13 of 39)